The Oncimmune Holdings PLC (ONC) Rating Reiterated by Beaufort Securities

The Oncimmune Holdings PLC (ONC) Rating Reiterated by Beaufort Securities

Shares of Oncimmune Holdings PLC (LON:ONC) opened at 141.00 on Thursday. Oncimmune Holdings PLC has a 52-week low of GBX 105.00 and a 52-week high of GBX 150.00. The firm’s market cap is GBX 71.94 million. The company has a 50 day moving average price of GBX 136.34 and a 200-day moving average price of GBX 125.95.

Oncimmune Holdings PLC (LON:ONC)‘s stock had its “speculative buy” rating restated by analysts at Beaufort Securities in a report issued on Thursday.

Oncimmune Holdings PLC Company Profile Oncimmune Holdings Plc is a cancer diagnosis company. The Company is engaged in developing and commercializing its EarlyCDT platform technology. Its geographical segments include United Kingdom, North America and Rest of the world. It is engaged in the development of autoantibody tests that can be applied to a range of solid tumor types.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “LSE:ONC”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Oncimmune Holdings PLC Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Oncimmune Holdings PLC and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment